Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDNA · against 242 other Healthcare companies of similar size
Ranked #166 of 243 · scores higher than 32% of peers · safety percentile 36
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)26 peers with a safety percentile of 30–39, including CDNA · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CDNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 235 reported | 0.05× | 0.24× | 74% | 33% | |
| BetaLower is better · 241 reported | 2.38 | 0.53 | 3% | 33% | |
| Current ratioHigher is better · 235 reported | 4.58× | 2.60× | 70% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 162 | 19.0B CNY (≈$2.7B) | 38 | 55 | |
| 163 | 7.4B USD | 37 | 67 | |
| 164 | 2.5B USD | 37 | 31 | |
| 165 | 22.1B CNY (≈$3.1B) | 36 | 49 | |
| 166 | 4.6B USD | 36 | 65 | |
| 167 | 3.6B AUD (≈$2.4B) | 36 | 59 | |
| 168 | 4.0B USD | 35 | 56 | |
| 169 | 74.2B SEK (≈$7.4B) | 35 | 55 | |
| 170 | 5.2B CHF (≈$5.9B) | 35 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score